BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$665M |
| 2 |
Apple
AAPL
|
+$408M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$402M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$223M |
| 5 |
NVIDIA
NVDA
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$970M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$389M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$350M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.77% |
| 2 | Consumer Discretionary | 6.67% |
| 3 | Healthcare | 6.55% |
| 4 | Financials | 6.32% |
| 5 | Communication Services | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
3551
Insight Molecular Diagnostics
IMDX
$147M
| $11.9K | ﹤0.01% |
663
-1,226
| -65% | -$27.9K |
|
3552
Zedge
ZDGE
$38.6M
| $11.8K | ﹤0.01% |
+4,113
| New | +$20.3K |
|
|
FRGI
3553
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $11.5K | ﹤0.01% |
1,610
-3,780
| -70% | -$26.7K |
|
|
AGS
3554
DELISTED
PlayAGS
AGS
| $11.4K | ﹤0.01% |
2,216
-22,475
| -91% | -$131K |
|
|
NVO
3555
CALL
Novo Nordisk
NVO
$203B
| $11.1K | ﹤0.01% |
+2
| New | +$111 |
|
3556
Ericsson
ERIC
$33.4B
| $11.1K | ﹤0.01% |
1,497
-30,056
| -95% | -$246K |
|
|
INFI
3557
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $10.9K | ﹤0.01% |
17,292
+9,431
| +120% | +$7.24K |
|
3558
Comp X International
CIX
$386M
| $10.8K | ﹤0.01% |
466
+181
| +64% | +$4.05K |
|
3559
American Superconductor
AMSC
$1.56B
| $10.7K | ﹤0.01% |
2,058
-27,614
| -93% | -$160K |
|
|
GTHX
3560
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $10.5K | ﹤0.01% |
2,133
-1,357
| -39% | -$7.51K |
|
3561
Hamilton Beach Brands
HBB
$443M
| $10.4K | ﹤0.01% |
837
-159
| -16% | -$1.68K |
|
3562
AC Immune
ACIU
$267M
| $10.4K | ﹤0.01% |
+2,869
| New | +$9.81K |
|
3563
Five Point Holdings
FPH
$372M
| $10.2K | ﹤0.01% |
2,607
-20,949
| -89% | -$108K |
|
|
ITI
3564
DELISTED
Iteris, Inc.
ITI
| $10.2K | ﹤0.01% |
3,513
-508
| -13% | -$1.41K |
|
3565
Nokia
NOK
$57.6B
| $10.1K | ﹤0.01% |
2,200
-3,398
| -61% | -$17K |
|
|
ARCE
3566
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $10.1K | ﹤0.01% |
676
-259
| -28% | -$4.53K |
|
3567
CALL
PG&E
PCG
$38.3B
| $9.98K | ﹤0.01% |
+10
| New | +$118 |
|
|
CSSE
3568
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $9.75K | ﹤0.01% |
1,316
-172
| -12% | -$1.32K |
|
3569
Standard BioTools
LAB
$312M
| $9.66K | ﹤0.01% |
6,035
-12,038
| -67% | -$29.8K |
|
3570
Mistras Group
MG
$556M
| $9.56K | ﹤0.01% |
1,609
-5,713
| -78% | -$33.8K |
|
3571
Smith Micro Software
SMSI
$17M
| $9.55K | ﹤0.01% |
97
-5
| -5% | -$581 |
|
|
LNAI
3572
Lunai Bioworks
LNAI
$10.7M
| $9.53K | ﹤0.01% |
62
+61
| +6,100% | +$27.9K |
|
3573
Cue Biopharma
CUE
$128M
| $9.02K | ﹤0.01% |
121
-126
| -51% | -$14.7K |
|
|
AMRN
3574
Amarin Corp
AMRN
$297M
| $8.96K | ﹤0.01% |
+301
| New | +$13K |
|
3575
Coca-Cola Femsa
KOF
$23.1B
| $8.85K | ﹤0.01% |
+160
| New | +$8.97K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2022 Portfolio in Review
As of Q2 2022, BNP Paribas Financial Markets held 4,360 positions worth $64.1B, down 14% from $74.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets's Q2 2022 filing shows 217 new, 1,899 increased, 1,581 reduced and 272 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M. The largest sale was Invesco QQQ Trust, an estimated $1.87B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2022 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2022, an estimated $665M increase.
- BNP Paribas Financial Markets's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.87B.
- BNP Paribas Financial Markets fully exited Warner Bros in Q2 2022, selling an estimated $27.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $64.1B portfolio in Q2 2022.
- BNP Paribas Financial Markets opened 217 new positions and closed 272 in Q2 2022.
- BNP Paribas Financial Markets's portfolio value fell 14% quarter-over-quarter to $64.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.